Slaughter and May is advising Thermo Fisher Scientific Inc. on the European competition law aspects of its US$7.2bn acquisition of Patheon N.V.

Slaughter and May is advising Thermo Fisher Scientific on the European competition law aspects of its US$7.2bn acquisition of Patheon N.V..

Patheon is a global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors.  Patheon employs approximately 9,000 professionals worldwide and in 2016 generated revenue of approximately US$1.9 billion.

Wachtell, Lipton, Rosen & Katz (M&A) and Axinn (North American competition) are also advising Thermo Fisher Scientific.